KIDSORTHOPEDIATRICS CORP

Nasdaq orthopediatrics.com


$ 33.22 $ -1.52 (-4.38 %)    

Wednesday, 08-May-2024 15:59:53 EDT
QQQ $ 439.55 $ -0.26 (-0.06 %)
DIA $ 390.50 $ 1.74 (0.45 %)
SPY $ 517.10 $ 0.05 (0.01 %)
TLT $ 90.18 $ -0.55 (-0.61 %)
GLD $ 213.58 $ -0.63 (-0.29 %)
$ 33.18
$ 34.18
$ 33.14 x 200
$ 33.24 x 200
$ 33.08 - $ 34.18
$ 23.10 - $ 48.47
153,267
na
757.19M
$ 0.95
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-31-2024 10-Q
2 03-08-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-01-2023 06-30-2023 10-Q
5 05-02-2023 03-31-2023 10-Q
6 03-01-2023 12-31-2022 10-K
7 11-01-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 03-03-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-05-2021 06-30-2021 10-Q
13 05-06-2021 03-31-2021 10-Q
14 03-11-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-06-2020 03-31-2020 10-Q
18 03-05-2020 12-31-2019 10-K
19 11-08-2019 09-30-2019 10-Q
20 08-13-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 03-07-2019 12-31-2018 10-K
23 10-31-2018 09-30-2018 10-Q
24 08-09-2018 06-30-2018 10-Q
25 05-15-2018 03-31-2018 10-Q
26 03-15-2018 12-31-2017 10-K
27 11-13-2017 09-30-2017 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 truist-securities-maintains-hold-on-orthopediatrics-raises-price-target-to-38

Truist Securities analyst Samuel Brodovsky maintains OrthoPediatrics (NASDAQ:KIDS) with a Hold and raises the price target f...

 needham-maintains-buy-on-orthopediatrics-raises-price-target-to-42

Needham analyst Mike Matson maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and raises the price target from $37 to $42.

 jmp-securities-reiterates-market-outperform-on-orthopediatrics-maintains-50-price-target

JMP Securities analyst David Turkaly reiterates OrthoPediatrics (NASDAQ:KIDS) with a Market Outperform and maintains $50 pri...

 orthopediatrics-q1-2024-adj-eps-030-beats-040-estimate-sales-44685m-beat-41775m-estimate

OrthoPediatrics (NASDAQ:KIDS) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.4...

 orthopediatrics-corp-receives-breakthrough-device-designation-from-fda-for-elli-growing-rod-system-for-pediatric-patients-with-scoliosis

OrthoPediatrics Corp. ("OrthoPediatrics") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediat...

 needham-reiterates-buy-on-orthopediatrics-maintains-37-price-target

Needham analyst Mike Matson reiterates OrthoPediatrics (NASDAQ:KIDS) with a Buy and maintains $37 price target.

 truist-securities-maintains-hold-on-orthopediatrics-raises-price-target-to-32

Truist Securities analyst Samuel Brodovsky maintains OrthoPediatrics (NASDAQ:KIDS) with a Hold and raises the price target f...

 stifel-maintains-buy-on-orthopediatrics-raises-price-target-to-34

Stifel analyst Rick Wise maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and raises the price target from $32 to $34.

 needham-reiterates-buy-on-orthopediatrics-maintains-37-price-target

Needham analyst Mike Matson reiterates OrthoPediatrics (NASDAQ:KIDS) with a Buy and maintains $37 price target.

 american-eagle-reports-upbeat-earnings-joins-kroger-burlington-stores-and-other-big-stocks-moving-higher-on-thursday

U.S. stocks were higher, with the Dow Jones index gaining more than 150 points on Thursday.

 jmp-securities-reiterates-market-outperform-on-orthopediatrics-maintains-50-price-target

JMP Securities analyst David Turkaly reiterates OrthoPediatrics (NASDAQ:KIDS) with a Market Outperform and maintains $50 pri...

 orthopediatrics-q4-2023-adj-eps-0230-beats-0280-estimate-sales-37613m-miss-37733m-estimate

OrthoPediatrics (NASDAQ:KIDS) reported quarterly losses of $(0.230) per share which beat the analyst consensus estimate of $(0....

 earnings-scheduled-for-march-6-2024

Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue o...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION